30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Steve Hill

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Steve Hill's trades of Cellectar Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-11-30 2018-11-29
S Sale
34,722 +32.0%
74.10
US$48,323 		34,722 +32.0% 74.10 US$48,323
2018-11-30 2018-11-29
S Sale
90,173 +43.0%
169.95
US$2,935,328 		90,173 +43.0% 169.95 US$2,935,328
2018-01-02 2017-12-29
US Lipocine Inc (LPCN)
PlS Planned sale
55,606 -36.2%
135.33
US$2,984,576 		55,606 -36.2% 135.33 US$2,984,576
2014-11-13 2014-11-13
US Lipocine Inc (LPCN)
B Purchase
4,000 +inf%
4.95
US$19,800 		4,000 +inf% 4.95 US$19,800
2014-08-22 2014-08-20
B Purchase
5,300 +inf%
3.75
US$19,875 		5,300 +inf% 3.75 US$19,875